Publication: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and mutation.
| dc.contributor.author | García-Silva, Susana | |
| dc.contributor.author | Benito-Martín, Alberto | |
| dc.contributor.author | Sánchez-Redondo, Sara | |
| dc.contributor.author | Hernández-Barranco, Alberto | |
| dc.contributor.author | Ximénez-Embún, Pilar | |
| dc.contributor.author | Nogués, Laura | |
| dc.contributor.author | Mazariegos, Marina S | |
| dc.contributor.author | Brinkmann, Kay | |
| dc.contributor.author | Amor López, Ana | |
| dc.contributor.author | Meyer, Lisa | |
| dc.contributor.author | Rodríguez, Carlos | |
| dc.contributor.author | García-Martín, Carmen | |
| dc.contributor.author | Boskovic, Jasminka | |
| dc.contributor.author | Letón, Rocío | |
| dc.contributor.author | Montero, Cristina | |
| dc.contributor.author | Robledo Batanero, Mercedes | |
| dc.contributor.author | Santambrogio, Laura | |
| dc.contributor.author | Sue Brady, Mary | |
| dc.contributor.author | Szumera-Ciećkiewicz, Anna | |
| dc.contributor.author | Kalinowska, Iwona | |
| dc.contributor.author | Skog, Johan | |
| dc.contributor.author | Noerholm, Mikkel | |
| dc.contributor.author | Muñoz, Javier | |
| dc.contributor.author | Ortiz-Romero, Pablo L | |
| dc.contributor.author | Ruano, Yolanda | |
| dc.contributor.author | Rodríguez-Peralto, José L | |
| dc.contributor.author | Rutkowski, Piotr | |
| dc.contributor.author | Peinado Selgas, Hector | |
| dc.contributor.funder | United States Department of Health & Human Services National Institutes of Health (NIH) - USA | |
| dc.contributor.funder | Feldstein Foundation | |
| dc.contributor.funder | Starr Cancer Consortium | |
| dc.contributor.funder | La Caixa Foundation | |
| dc.contributor.funder | Fundacion Cientifica Asociacion Espanola Contra el Cancer | |
| dc.contributor.funder | Ramon Areces Foundation | |
| dc.contributor.funder | Comunidad de Madrid (España) | |
| dc.contributor.funder | Ministerio de Ciencia y Competetividad (España) | |
| dc.date.accessioned | 2025-01-07T17:05:53Z | |
| dc.date.available | 2025-01-07T17:05:53Z | |
| dc.date.issued | 2019-05-06 | |
| dc.description | This work was supported by the US National Institutes of Health (R01-CA169416), the Feldstein Foundation, the Starr Cancer Consortium, Ministerio de Economia y Competitividad, the Ramon y Cajal Program, Atresmedia-Fundacion AXA, "La Caixa" Foundation (ID 100010434, Fellowship LCF/BQ/ES17/11600007), Fundacion Cientifica Asociacion Espanola Contra el Cancer, Fundacion de Investigacion Oncologica, Ministerio de Economia y Competitividad-Red de Excelencia en Investigacion e Innovacion en Exosomas, the Ramon Areces Foundation, and Comunidad Autonoma de Madrid. | |
| dc.description.abstract | Liquid biopsies from cancer patients have the potential to improve diagnosis and prognosis. The assessment of surrogate markers of tumor progression in circulating extracellular vesicles could be a powerful non-invasive approach in this setting. We have characterized extracellular vesicles purified from the lymphatic drainage also known as exudative seroma (ES) of stage III melanoma patients obtained after lymphadenectomy. Proteomic analysis showed that seroma-derived exosomes are enriched in proteins resembling melanoma progression. In addition, we found that the mutation can be detected in ES-derived extracellular vesicles and its detection correlated with patients at risk of relapse. | |
| dc.description.peerreviewed | Sí | |
| dc.format.number | 5 | |
| dc.format.page | 1061-1070 | |
| dc.format.volume | 216 | |
| dc.identifier.citation | J Exp Med . 2019 May 6;216(5):1061-1070. | |
| dc.identifier.journal | Journal of Experimental Medicine | |
| dc.identifier.pubmedID | 30975894 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/25958 | |
| dc.language.iso | eng | |
| dc.publisher | Rockefeller University Press | |
| dc.relation.publisherversion | http:// 10.1084/jem.20181522 | |
| dc.repisalud.institucion | CNIO | |
| dc.repisalud.orgCNIO | CNIO::Grupos de investigación::Grupo de Microambiente y Metástasis | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | MUTANT KRAS | |
| dc.subject | EXOXOME | |
| dc.subject | DNA CELLS | |
| dc.title | Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and mutation. | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 400c30f1-1f41-4b0d-8b2e-327d5b9c3e7e | |
| relation.isAuthorOfPublication | e5c716e0-8396-45cb-a653-686569945266 | |
| relation.isAuthorOfPublication | f33d0f5a-ce2e-4874-a2d8-03c0974e8b1d | |
| relation.isAuthorOfPublication.latestForDiscovery | 400c30f1-1f41-4b0d-8b2e-327d5b9c3e7e |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- useofextracellularvesicles_2019.pdf
- Size:
- 2.39 MB
- Format:
- Adobe Portable Document Format


